Hepatitis B Virus
Hepatitis B virus genotype response to long-term lamivudine treatment clarified
Published in Hepatitis Weekly, October 30th, 2006
"Response to lamivudine treatment longer than 1 year was compared in 15 patients persistently infected with HBV genotype A, 38 with genotype B, and 449 with genotype C," wrote M. Kobayashi and colleagues, Toranomon General Hospital.
"Patients with genotype A were younger (median age 37 [range 24-49] vs. 47 [24-67] or 44 [18-73], p=.015), possessed hepatitis B e antigen (HBeAg) more frequently (73% vs. 21% or 56%, p<.001) and HBV DNA in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-10-30)
More Articles from Hepatitis Weekly
- Apoptosis
Virus-induced hepatocyte apoptosis is mediated by a transcription factor - Hepatitis B Virus
Hepatitis B virus lamivudine-resistant mutations rapidly detected - Hepatitis B Virus
Hepatitis B virus multi-drug resistance evolves during sequential therapy - Hepatitis B Virus
Hepatitis B virus residue phosphorylation facilitates core assembly - Hepatitis C Virus
Hepatitis C virus treatment response predicted - Hepatitis B Virus
New findings from University of Hong Kong, Department of Medicine in the area of hepatitis b virus published - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
